biolifesolutions.com (BLFS) - Utang marang Ekuitas

BLFS (BioLife Solutions, Inc.) - tandha merek perusahaan

A recovery in biotech investments and FDA approvals are driving growth for BioLife Solutions, Inc. (BLFS). The debt-to-equity ratio confirms this trend, as the metric remains around 0.04. Stability is ensured by the company's role as a critical link in regenerative medicine logistics and the delegation of raw material procurement to reliable partners under strict internal quality control.

BLFS: Total Utang marang Modal biolifesolutions.com 04.07.2022 - 18.10.2026

Rincian metrik komprehensif lan analitis BioLife (BLFS)

- rega lan prakiraan konsensus rega:
Rega saham BioLife Solutions|BLFS - Prakiraan gabungan firma investasi
- data kapitalisasi pasar:
Nilai pasar BioLife Solutions|BLFS - Nilai Bisnis
- data kapitalisasi buku:
Nilai Buku saben Saham BioLife Solutions|BLFS - Kapitalisasi Buku|Rasio Kapitalisasi Pasar marang Nilai Buku biolifesolutions.com|BLFS - Aset Agregat Perusahaan
- data utang lan likuiditas:
Total Utang marang Modal BioLife Solutions, Inc.|BLFS - Rasio tanggungan utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas BioLife Solutions, Inc.|BLFS - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku BioLife Solutions
Ringkesan analisis perusahaan:BLFS, BioLife Solutions
Barang unggulan BioLife Solutions, Inc.

BioLife Solutions, Inc. (BLFS) provides the biopharmaceutical sector with critical freezing systems and consumables. This indicator compares total liabilities to net assets, determining the volume of debt financing per unit of equity. The metric allows for an assessment of financial stability and the extent of the business's dependence on external creditors. A low debt load confirms the effectiveness of the company's niche strategy. By analyzing the debt-to-equity ratio chart, an investor determines the risks of future interest payments.

Pesaing utama

Total Utang marang Modal tempus.com (TEM)|Rasio Utang marang Ekuitas QGEN|Utang marang Ekuitas Ionis Pharma IONS|Rasio Utang marang Ekuitas Repligen Inc. (RGEN)|Total Utang marang Modal RNA (Avidity Biosciences)|Total Utang marang Modal crisprtx.com CRSP|WGS - Total Utang marang Modal|RARE - Utang marang Ekuitas|Beam Therapeutics Corp - Total Utang marang Modal|SRPT (Sarepta Corp) - Koefisien Total Utang marang Modal|Utang marang Ekuitas TWST (Twist Bioscience)|Utang marang Modal TXG|Utang marang Ekuitas Intellia Therapeutics, Inc. (NTLA)|Utang marang Ekuitas Stoke Therapeutics Inc (STOK)|Total Utang marang Modal WVE|Koefisien Total Utang marang Modal Maze Therapeutics Corp MAZE|Total Utang marang Modal Sionna Therapeutics Inc|PRME - Utang Agregat marang Ekuitas|Total Utang marang Modal TSHA|Utang marang Modal uniQure NV|MGTX - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi RGNX|SLDB (Solid Biosciences Inc.) - Utang marang Ekuitas|Koefisien Total Utang marang Modal OCGN (ocugen.com)|PACB: Utang marang Ekuitas|Benitec Biopharma Inc - Utang marang Modal|DSGN - Utang marang Ekuitas|Rocket Corp (RCKT) - Utang marang Ekuitas|FDMT: Rasio Total Utang marang Ekuitas|Total Utang marang Modal Lexeo Therapeutics, Inc.|Korro Bio Inc. (KRRO) - Rasio Total Utang marang Ekuitas|Utang Agregat marang Modal Editas Medicine Inc|SLN (Silence Therapeutics Inc.) - Total Utang marang Modal|Koefisien Total Utang marang Modal PRQR (proqr.com)|CDXS: Utang marang Ekuitas|sangamo.com - Utang marang Modal|Nautilus Biotechnology Inc (NAUT) - Utang marang Ekuitas|MGX: Rasio Utang marang Ekuitas|Precision BioSciences, Inc. - Utang marang Ekuitas|Koefisien Total Utang marang Modal Generation Bio|BOLD - Rasio Total Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi Exicure Corp|IMNN (Imunon, Inc.) - Total Utang marang Modal|Koefisien Total Utang marang Modal PHIO (phiopharma.com)|MBIO - Utang marang Ekuitas|Rasio Utang marang Ekuitas TransCode Therapeutics Inc. RNAZ|BNGO: Total Utang marang Modal|adnas.com (APDN) - Rasio Total Utang marang Ekuitas|bluebird bio - Rasio Total Utang marang Ekuitas|ImmunoPrecise Antibodies Ltd. (IPA) - Koefisien Total Utang marang Modal|Total Utang marang Modal Omega|Utang marang Ekuitas OMIC|Utang marang Ekuitas Regulus Therapeutics (RGLS)|Utang marang Ekuitas syros.com (SYRS)|Telesis Bio (TBIO) - Total Utang marang Modal|TRACON Pharmaceuticals Inc. - Utang Agregat marang Ekuitas|Utang marang Ekuitas UBX (Unity Bio)